Comparative evaluation of acteoside and silymarin as hepatoprotective agents in acute hepatitis patients.
Phase 2
- Registration Number
- CTRI/2008/091/000247
- Lead Sponsor
- Government Medical College, Jammu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Acute Hepatitis Patients of different etiologies in the age group of 20-65 years and would be required to abstain from any alternative medication or vitamin supplements during the study.
Exclusion Criteria
1. Patients having any other concomitant disease
2.Patients receiving any other medication affecting hepatic function
3. Patients having received any hepatoprotective agent in the recent past or currently on any hepatoprotective agent 4.Patients with history of smoking, alcohol or any other substance abuse.
5. Pregnancy and lactation.
6. Has participated in any investigational study 4 weeks prior to the enrollment in this study.
7. Known history of hypersensitivity reactions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method